is takeover a real possibility

With the apparent commencement of Ph III trials, which according to the FDA website indicates positive data from the Ph IIb trials, I am beginning to wonder if a takeover is not a distinct possibility sooner rather than later?

Even considering GFC2, it seems strange to me that, conveniently, right after a huge capital raising our SP has halved in price, despite the fact there has been many positive announcements since then.

We have obvious bot trading in place keeping the SP in a certain range, IMO for accumulation. A hostile bid perhaps?

Is the delay in Nasdaq listing connected anyhow? It would more than likely be an American company taking us over?

Would the commencement of both Ph III trials (positive ph IIb) and treatment of patients in Dubai be enough for a predator to take a gamble, particularly given the impending patent cliff and CVac's multi blockbuster potential???

I would love to hear other peoples opinions on this...

And for the record, given PRR's potential, I would consider $1.20 an insult and would personally not entertain anything less that $3!